Strategic Competitive Intelligence and the role of the Microbiome in Immuno-Oncology
cancer immuno-therapy, immuno-oncology, microbiome, strategic competitive intelligence, tumour mutation burden
0 Comment
Immuno-Oncology Conference – London – September